Evidence map›Paper›PMID 42578144›Full record

ArticleThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG2026

Potential Dangers of Adult Cosmetics to Preteen and Teenage Girls.

Kate E Myers, Talia Thomas, Gregory L Kearns

Abstract read
In one paragraph

Article in The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kate E MyersThe Departments of Medical Education (KEM, TT) and Pediatrics (GLK), the Anne Burnett Marion School of Medicine at Texas Christian University, Fort Worth, TX.
Talia ThomasThe Departments of Medical Education (KEM, TT) and Pediatrics (GLK), the Anne Burnett Marion School of Medicine at Texas Christian University, Fort Worth, TX.
Gregory L KearnsThe Departments of Medical Education (KEM, TT) and Pediatrics (GLK), the Anne Burnett Marion School of Medicine at Texas Christian University, Fort Worth, TX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cosmetic use among preteens and adolescents is increasingly common, fueled by social media trends and marketing campaigns that blur the lines between childhood innocence and adult beauty culture. Although these products are often marketed as safe, many contain chemicals of concern, including endocrine-disruptions agents, allergens, and potential carcinogens. Early and prolonged exposure during critical stages of growth raises important questions about immediate and long-term health consequences. Children and teenagers are particularly vulnerable because their skin barrier is thinner and more permeable than that of adults, allowing greater absorption of harmful substances. Endocrine-disrupting chemicals interfere with normal hormonal pathways, potentially altering physical development and reproductive health. Fragrances and preservatives may provoke allergic or irritant reactions, leading to dermatologic conditions such as contact dermatitis and acne exacerbation. Cumulative exposure over years may also increase the risk of cellular damage or malignancy. Beyond physical effects, cosmetic use during adolescence carries psychosocial implications. Engagement with appearance-focused products reinforces unattainable beauty ideals, heightens self-consciousness, and may increase anxiety, body dissatisfaction, and eating-disorder behaviors. These risks are amplified by advertising practices that emphasize perfection while concealing potential harms. Strengthening regulation, ingredient transparency, age-specific safety testing, and public health education is needed to safeguard adolescent well-being.

Indexed as

beautycosmeticsgirlspreteenteenagers

Identifiers

PMID42578144
PMCPMC13456151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.